ArticleJournal of materials chemistry. A2016
Efficient and selective oxidation of sulfur mustard using singlet oxygen generated by a pyrene-based metal-organic framework.
Article in Journal of materials chemistry. A, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 186 citations in OpenAlex.
- Advancing Metal-Organic Framework-Based Composites for Effective Chemical Warfare Agent Detoxification under Real-World Conditions.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Accelerated oxidation of mustard gas analog with PVA-based hydrogels.RSC advances · 2025Article
- Aerobic Photodegradation of Pyrene-Based Metal-Organic Framework NU-1000 to Terephthalic Acid.Chemistry of materials : a publication of the American Chemical Society · 2025Article
- Oxidative Neutralisation of Sulfur-Based Chemical Warfare Agents Mediated by a Lipase: From Batch to Flow Reactor.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
- Donor-acceptor engineering of a triplet-exciton-optimized MOF photocatalyst for efficient singlet oxygen-mediated oxidation.National science review · 2025Article
- Metalloporphyrinic metal-organic frameworks for enhanced photocatalytic degradation of a mustard gas simulant.Chemical communications (Cambridge, England) · 2024Article
- Adsorption in Pyrene-Based Metal-Organic Frameworks: The Role of Pore Structure and Topology.ACS applied materials & interfaces · 2024Article
- Selective and efficient detoxification of sulfur mustard gas analogues with HACS catalysis · 2024Article
- Advances in Metal-Organic Frameworks for the Removal of Chemical Warfare Agents: Insights into Hydrolysis and Oxidation Reaction Mechanisms.Nanomaterials (Basel, Switzerland) · 2023Review
- Article
- A solvent-free solid catalyst for the selective and color-indicating ambient-air removal of sulfur mustard.Communications chemistry · 2021Article
- Chemical targets to deactivate biological and chemical toxins using surfaces and fabrics.Nature reviews. Chemistry · 2021Review
- Regioselective Functionalization of the Mesoporous Metal-Organic Framework, NU-1000, with Photo-Active Tris-(2,2'-bipyridine)ruthenium(II).ACS omega · 2020Article
- Visible-light harvesting pyrene-based MOFs as efficient ROS generators.Chemical science · 2019Article
- Air oxidation of sulfur mustard gas simulants using a pyrene-based metal-organic framework photocatalyst.Beilstein journal of nanotechnology · 2019Article
- Pyrene-based metal-organic framework NU-1000 photocatalysed atom-transfer radical addition for iodoperfluoroalkylation and (RSC advances · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
Abstract
A pyrene-based metal-organic framework (MOF) NU-1000 was used as a heterogeneous photocatalyst for the degradation of a sulfur mustard simulant, 2-chloroethyl ethyl sulfide (CEES). Using irradiation from a commercially available and inexpensive ultraviolet (UV) light-emitting diode (LED), singlet oxygen (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.